COF vs COLL · P/E 62, rev $53.43B vs P/E 17, rev $181.9M
Capital One Financial Corporation (COF) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Capital One Financial Corporation (COF) is a credit services company listed on NYSE.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported COF revenue for 2025-12-31 was $53.43B. Net income was $2.45B. Revenue was up 36.6% from 2024-12-31 to 2025-12-31. COF currently screens at market cap $125.00B and trailing P/E 61.8.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
COF currently screens at market cap $125.00B and trailing P/E 61.8. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the COF and COLL stock pages for the full models.
Not investment advice.